Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000710555 | SCV000840796 | benign | not provided | 2018-04-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311997 | SCV000846914 | likely benign | Inborn genetic diseases | 2016-06-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001083814 | SCV001012269 | benign | KBG syndrome | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710555 | SCV001842379 | benign | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001083814 | SCV002524182 | benign | KBG syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000710555 | SCV004143487 | benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | ANKRD11: BP4, BP7, BS1, BS2 |